New York State Cancer Registry
Registry Data
- 19,611,813Total Population Count
- 6.1%% of US Population
- 8.0%% of US Black Population
- 8.7%% of US API Population
- 1.9%% of US AI/AN* Population
- 6.4%% of US Hispanic Population
- 14.6%% of US Hispanic Non-White Population
*CHSDA Counties only
- 114,167Malignant Cases
- 6.7%% of US Malignant Cases
NPCR/SEER
1976
1995
Yes
1995-2015
2008-2014
Yes
Study Participation
Research Type | Experience with Studies | Interested in Studies |
---|---|---|
Case Contacts Studies | Yes | Yes |
Geospatial Studies | Yes | Yes |
Linkage Studies | Yes | Yes |
Rapid Case Ascertainment Studies | Yes | No |
Re-Abstracting/Patterns of Care Studies | Yes | No |
Survival Studies | No | Yes |
Contact Information
Login is required to access this information. Log In with your MyNAACCR account.
Required Review(s) and Initial Contact
Both local/state IRB review and Registry review
Yes
Registry form for both reviews
No
Cancer Registry
Local/State IRB Review Requirements
New York State Dept of Hlth
FWA00003700
No
Every other month
Registry Review Requirements
Registry Data Request Form URL(s)URL | Description | |
---|---|---|
http://nyscr@health.ny.gov | General NYSCR mail for initial requests | |
http://tabassum.insaf@health.ny.gov. | The researcher first contacts Tabassum Insaf, the NY State Cancer Registry Director, at 518-474-2225 or by email at tabassum.insaf@health.ny.gov. |
Monthly
No URLs specified.
Registry Data Use (or Research) Agreement URL(s)No URLs specified.
Process
3-6 months
3-6 months
Yes
No
Login is required to access this information. Log In with your MyNAACCR account.
Login is required to access this information. Log In with your MyNAACCR account.
If the study involves patient contact, Cancer Registry staff must first obtain patient consent, or if patient is too ill or deceased, next-of-kin consent, to release the patient’s name to the researcher.
Additional Cancer Registry requirements and charges may apply.
The Cancer Registry will first notify the physician, then they will notify the patient about the study and require patient consent to release name and address.
Patient release is not required for cohort studies that involve linkage to the Cancer Registry in order to ascertain cancer occurrence. However, if the study involves contacting individuals identified as having cancer through the linkage in order to obtain information regarding their cancer (e.g., risk factor information, medical record release, etc.), then patient release is required.
Yes
Data Use and Renewal Requirements
As noted in approved documents (e.g. IRB/Registry Application, DUA, Confidentiality Agreement)
No
N/A
None
Annual
30 days
Yes
Consent Requirements
Yes - Passive
Registry
Registry
No
Registry fees
Yes
After researcher receives data
VPR studies
No charges for phase 1 study
Phase 2 linkage : $3000 flat fee for studies requiring no manual review
For studies requiring manual review: 3000$ flat fee +additional $14 per record after first 100 records
External research studies (e.g., non-VPR cohort linkages, or other studies involving new data match):
Number of
Records Total Service
Fee Charged
1. Fewer than 10,000 $ 3,000
2. 10,000 – 49,999 $ 4,500
3. 50,000 – 99,999 $ 6,000
4. 100,000 – 249, 999 $ 7,500
5. 250,000 – 499,999 $ 10,000
6. 500,000 – 999,999 $12,500
7. More than 1,000,000 $15,000
For studies requiring case listing only such as simple data pulls or those requiring SPARCS and/or vital records linkage only (without cohort matching): flat fee of $3000.
For very small cohorts, involving individual case look-ups, the Registry fee will be $14 per record plus $500 flat fee.
For Patient contact studies: Researcher needs to discuss structure of study with DOH researchers. Usually these would require that DOH researchers participate as active collaborators and external researcher will need to provide a subcontract to fund staff time and supplies for patient and physician mailing and follow up.
Repeat linkages are eligible for a 20% reduction, depending on the work involved.
Note: With the exception of patient contact studies, fee can be waived for active collaborations and/or when researcher cannot pay based on discussion with the NYS Cancer Registry’s Internal Peer Review Committee.
IRB fees
No